advertisement
11.3.4 Betablocker (10)
Showing records 1 to 10
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker10644 A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe
Garcia-Sanchez J; Rouland JF; Spiegel D; Pajic B; Cunliffe I; Traverso C; Landry J
British Journal of Ophthalmology 2004; 88: 877-83
10624 Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma
Erkin EF; Tarhan S; Kayikcioglu OR; Deveci H; Guler C; Goktan C
European Journal of Ophthalmology 2004; 14: 211-9
10638 Comparing the fixed combination dorzolamide-timolol (Cosopt®) to concomitant administration of 2% dorzolamide (TrusoptR) and 0.5% timolol - A randomized controlled trial and a replacement study
Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS
Journal of Clinical Pharmacy and Therapeutics 2004; 29: 375-380
10700 Effects of carteolol hydrochloride on the in vitro production of LPS-induced proinflammatory cytokines by murine macrophage
Kawai K; Kuwahara K; Oizumi N; Kitagaki H; Fujisawa S
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 237-245
10777 A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension
Mundorf TK; Ogawa T; Naka H; Novack GD; Stephens Crockett R
Clinical Therapeutics 2004; 26: 541-551
10849 Sustained perimacular vascular and visual response to topical beta blockers in normal human eyes
Sponsel WE
Brain Research Bulletin 2004; 62: 529-35
10859 Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: An eight-week, randomized, open-label, parallel-group, multicenter study in Latin America
Susanna Jr R; Sheu W-P
Clinical Therapeutics 2004; 26: 755-768
10923 Are there any benefits of Betoptic® S (betaxolol HCl ophthalmic suspension) over other β-blockers in the treatment of glaucoma?
Yarangumeli A; Kural G
Expert Opinion in Pharmacotherapy 2004; 5: 1071-1081
10684 Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension
Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y
Japanese Journal of Ophthalmology 2004; 48: 276-80
10879 Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide
Toris CB; Zhan GL; Yablonski ME; Camras CB
Journal of Glaucoma 2004; 13: 210-5
